Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Income from Non-Controlling Interests (2016 - 2018)

Historic Income from Non-Controlling Interests for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 9 years, with Q2 2018 value amounting to $4000.0.

  • Lifecore Biomedical, Inc. \De\'s Income from Non-Controlling Interests fell 6666.67% to $4000.0 in Q2 2018 from the same period last year, while for May 2019 it was $2000.0, marking a year-over-year decrease of 9787.23%. This contributed to the annual value of $94000.0 for FY2018, which is 804.6% up from last year.
  • Latest data reveals that Lifecore Biomedical, Inc. \De\ reported Income from Non-Controlling Interests of $4000.0 as of Q2 2018, which was down 6666.67% from -$2000.0 recorded in Q1 2018.
  • Lifecore Biomedical, Inc. \De\'s Income from Non-Controlling Interests' 5-year high stood at $74000.0 during Q2 2014, with a 5-year trough of -$6000.0 in Q1 2017.
  • For the 5-year period, Lifecore Biomedical, Inc. \De\'s Income from Non-Controlling Interests averaged around $36166.7, with its median value being $32000.0 (2015).
  • In the last 5 years, Lifecore Biomedical, Inc. \De\'s Income from Non-Controlling Interests soared by 63333.33% in 2014 and then tumbled by 12608.7% in 2017.
  • Quarter analysis of 5 years shows Lifecore Biomedical, Inc. \De\'s Income from Non-Controlling Interests stood at $24000.0 in 2014, then skyrocketed by 150.0% to $60000.0 in 2015, then dropped by 20.0% to $48000.0 in 2016, then plummeted by 45.83% to $26000.0 in 2017, then tumbled by 84.62% to $4000.0 in 2018.
  • Its last three reported values are $4000.0 in Q2 2018, -$2000.0 for Q1 2018, and $26000.0 during Q4 2017.